✦ LIBER ✦

Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma

✍ Scribed by Gregory M. Cote; Ephraim P. Hochberg; Alona Muzikansky; Fred H. Hochberg; Jan Drappatz; Steven L. McAfee; Tracy T. Batchelor; Ann S. LaCasce; David C. Fisher; Jeremy S. Abramson; Philippe Armand; Yi-Bin Chen

Book ID: 115538364
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 235 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.07.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of High-Dose Rituximab wi

Phase II Trial of High-Dose Rituximab with Thiotepa/Busulfan/Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma

✍ Chen, Yi-Bin; Batchelor, Tracy; Hochberg, Ephraim; Brezina, Mark; Coughlin, Erin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Superior survival after replacing oral w

Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide

✍ Robert M. Dean; Brad Pohlman; John W. Sweetenham; Ronald M. Sobecks; Matt E. Kal 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

High-dose thiotepa, etoposide and carbop

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma

✍ Franca Falzetti,Mauro Di Ianni,Stelvio Ballanti… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 235 KB

Busulfan and Cyclophosphamide (Bu/Cy) as

Busulfan and Cyclophosphamide (Bu/Cy) as a Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma: A Single-Institution Experience

✍ Matthew Ulrickson; Julie Aldridge; Haesook T. Kim; Ephraim P. Hochberg; Peter Ha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Multicenter study of intravenous busulfa

Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma

✍ Kim, J G; Sohn, S K; Chae, Y S; Yang, D H; Lee, J-J; Kim, H-J; Shin, H J; Jung, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Busulfan, Cyclophosphamide, Etoposide (B

Busulfan, Cyclophosphamide, Etoposide (BUCYVP) or Carmustine, Etoposide, Cytarabine, Melphelan (BEAM) for Conditioning Prior to Autologous Stem Cell Transplantation (ASCT) in Patients with Hodgkin Lymphoma (HL)?

✍ G. Salem; A.S. Ruppert; Y. Efebera; P. Elder; A. Bingman; S. Penza; L.A. Andrits 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB